ÂÜÀòÂÒÂ×

Mr. Titus is currently Chief Financial Officer of CyanVac LLC and its affiliate, Blue Lake Biotechnology. Mr. Titus has more than 25 years of business experience in the healthcare and biopharmaceutical industries, primarily in senior management roles. Mr. Titus was CFO of UroGen Pharma LTD, where he led the successful IPO, from 2015 to 2018. Prior to that, Mr. Titus held the position of CFO of BioCardia, Inc. Prior to that, from 2008 to 2013, Mr. Titus was SVP and CFO at SciClone Pharmaceuticals, Inc. From 2006 to 2008, Mr. Titus was Senior VP of Finance and CFO at Kosan Biosciences, Inc. From 2003 to 2006, he was CFO and VP at Nuvelo, Inc. Earlier in his career, Mr. Titus held a variety of positions at other companies, including Metabolex, Inc., Intrabiotics Pharmaceuticals, Inc. and Johnson & Johnson. He has held public Board of Director positions as Audit Committee Chair and Chairman of the Board. Mr. Titus holds a B.Sc. in Accounting from the University of South Florida and a B.Sc. in Finance from the University of Florida. Mr. Titus also completed the Global BioExecutive Program at the University of California Berkeley’s Haas School of Business.